“It will not have been lost upon the physician who has read the remarks on the use of Aromatic Liquid Albolene to regulate the bowels in surgical cases, that there are many instances where it would prove equally valuable during the treatment of acute diseases. In the exanthemata, in pneumonia, for example, to cite only a few of the conditions where it may be used to advantage, an absolutely reliable laxative that will not in any way weaken or distress the patient, presents obvious superiority to any of the agents heretofore in common use.”
The Council held Liquid Albolene ineligible because the product is marketed in a way to encourage its indiscriminate and irrational use by the public (Rule 4) and because unwarranted therapeutic claims are made for it (Rule 6).—(From Reports of Council on Pharmacy and Chemistry, 1916, p. 65.)
NAPHEY’S MEDICATED UTERINE WAFERS
Report of the Council on Pharmacy and Chemistry
Naphey’s Medicated Uterine Wafers were submitted to the Council by the manufacturers, Naphey & Co., some years ago and were rejected. Naphey & Co. has recently requested reconsideration of the preparation, and has submitted advertising matter, trade packages and sample packages. The label of the trade package contains the following:
“Naphey’s Wafers. For the local treatment of diseases of women, indicated in catarrhal conditions of the vagina, and of the uterine cervix. As a [sic!] adjuvant for the physician to use in carrying out treatment of disease of the uterus.”
“Zinc Sulphate, 33⁄4 gr., Sodium Sulphate, 31⁄2 gr., Sodium Borate, 4 gr., Boric Acid, 3⁄4 gr.”
“Naphey & Co., Warren, Pa., U. S. A.”
“Each box contains 25 wafers, sufficient for three months’ treatment. Price per box, 25c.”